These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26400567)

  • 41. Semaphorin3a promotes advanced diabetic nephropathy.
    Aggarwal PK; Veron D; Thomas DB; Siegel D; Moeckel G; Kashgarian M; Tufro A
    Diabetes; 2015 May; 64(5):1743-59. PubMed ID: 25475434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
    Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
    Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
    Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraglomerular crosstalk elaborately regulates podocyte injury and repair in diabetic patients: insights from a 3D multiscale modeling study.
    Tan H; Yi H; Zhao W; Ma JX; Zhang Y; Zhou X
    Oncotarget; 2016 Nov; 7(45):73130-73146. PubMed ID: 27683034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.
    Ma J; Chen X; Li JS; Peng L; Wei SY; Zhao SL; Li T; Zhu D; He YX; Wei QJ; Li B
    Endocrine; 2015 Jun; 49(2):373-84. PubMed ID: 25424436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
    Sawai K; Mukoyama M; Mori K; Yokoi H; Koshikawa M; Yoshioka T; Takeda R; Sugawara A; Kuwahara T; Saleem MA; Ogawa O; Nakao K
    Nephrol Dial Transplant; 2006 Sep; 21(9):2472-7. PubMed ID: 16820374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renin-angiotensin system within the diabetic podocyte.
    Márquez E; Riera M; Pascual J; Soler MJ
    Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
    Ito Y; Hsu MF; Bettaieb A; Koike S; Mello A; Calvo-Rubio M; Villalba JM; Haj FG
    Metabolism; 2017 Nov; 76():56-69. PubMed ID: 28987240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
    Chen LP; Zhou QL; Peng WS; Wu XY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
    Liu Y; Li H; Liu J; Han P; Li X; Bai H; Zhang C; Sun X; Teng Y; Zhang Y; Yuan X; Chu Y; Zhao B
    J Am Soc Nephrol; 2017 Dec; 28(12):3627-3638. PubMed ID: 28923913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MAD2B contributes to podocyte injury of diabetic nephropathy via inducing cyclin B1 and Skp2 accumulation.
    Su H; Wan Q; Tian XJ; He FF; Gao P; Tang H; Ye C; Fan D; Chen S; Wang YM; Meng XF; Zhang C
    Am J Physiol Renal Physiol; 2015 Apr; 308(7):F728-36. PubMed ID: 25651564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy.
    Wang X; Liu J; Zhen J; Zhang C; Wan Q; Liu G; Wei X; Zhang Y; Wang Z; Han H; Xu H; Bao C; Song Z; Zhang X; Li N; Yi F
    Kidney Int; 2014 Oct; 86(4):712-25. PubMed ID: 24717296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wnt/β-Catenin Signaling Mediated-UCH-L1 Expression in Podocytes of Diabetic Nephropathy.
    Zhang H; Luo W; Sun Y; Qiao Y; Zhang L; Zhao Z; Lv S
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteinuria: abate or applaud abatacept in proteinuric kidney disease?
    Reiser J; Alachkar N
    Nat Rev Nephrol; 2014 Mar; 10(3):128-30. PubMed ID: 24375054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome.
    Trachtman H; Gipson DS; Somers M; Spino C; Adler S; Holzman L; Kopp JB; Sedor J; Overfield S; Elegbe A; Maldonado M; Greka A
    Kidney Int Rep; 2018 Jan; 3(1):115-121. PubMed ID: 29340321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.